Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China
Microbial Drug Resistance · 2023
DOI: 10.1089/mdr.2022.0216 ↗Kurz gefasst
Leserbrief in der Zeitschrift Microbial Drug Resistance, 2023. Verfasst von Huiwen Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Respiratory Diseases, Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Beijing Pediatric Research Institute, Beijing…. Hauptthemen laut MEDLINE: Oxazolidinones, Mycobacterium Infections, Nontuberculous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Respiratory Diseases, Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Ma…
- National Tuberculosis Reference Laboratory, Chinese Center for Disease Control and Prevention, Beijing, China.
- Institute for Immunization and Prevention, Beijing Center for Disease Control and Prevention, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control, Beijing, China.
Zitieren
APA
Zheng, H., Wang, Y., He, W., Li, F., Xia, H., Xiao, J., Ou, X., Wang, S., Shen, C., & Zhao, Y. (2023). Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2022.0216
Vancouver
Zheng H, Wang Y, He W, Li F, Xia H, Xiao J, et al. Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China. Microbial Drug Resistance. 2023. doi:10.1089/mdr.2022.0216
BibTeX
@article{Zheng2023,
author = {Zheng, Huiwen and Wang, Yiting and He, Wencong and Li, Feina and Xia, Hui and Xiao, Jing and Ou, Xichao and Wang, Shengfen and Shen, Chen and Zhao, Yanlin},
title = {Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China},
journal = {Microbial Drug Resistance},
year = {2023},
doi = {10.1089/mdr.2022.0216}
}
EUVIMED